Homo sapiens Protein: KCTD7
Summary
InnateDB Protein IDBP-376893.5
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol KCTD7
Protein Name potassium channel tetramerisation domain containing 7
Synonyms
Species Homo sapiens
Ensembl Protein ENSP00000411624
InnateDB Gene IDBG-408379 (KCTD7)
Protein Structure
UniProt Annotation
Function May be involved in the control of excitability of cortical neurons. {ECO:0000250}.
Subcellular Localization Cell membrane. Cytoplasm, cytosol.
Disease Associations Epilepsy, progressive myoclonic 3, with or without intracellular inclusions (EPM3) [MIM:611726]: An autosomal recessive, severe, progressive myoclonic epilepsy with early onset. Multifocal myoclonic seizures begin between 16 and 24 months of age after normal initial development. Neurodegeneration and regression occur with seizure onset. Other features include mental retardation, dysarthria, truncal ataxia, and loss of fine finger movements. EEG shows slow dysrhythmia, multifocal and occasionally generalized epileptiform discharges. In some patients, ultrastructural findings on skin biopsies identify intracellular accumulation of autofluorescent lipopigment storage material, consistent with neuronal ceroid lipofuscinosis. {ECO:0000269PubMed:17455289, ECO:0000269PubMed:22606975, ECO:0000269PubMed:22693283, ECO:0000269PubMed:22748208}. Note=The disease is caused by mutations affecting the gene represented in this entry.Note=Defects in KCTD7 are a cause of opsoclonus-myoclonus ataxia-like syndrome. Opsoclonus myoclonus ataxia syndrome (OMS) is a rare pervasive and frequently permanent disorder that usually develops in previously healthy children with normal premorbid psychomotor development and characterized by association of abnormal eye movements (opsoclonus), severe dyskinesia (myoclonus), cerebellar ataxia, functional regression, and behavioral problems. The syndrome is considered to be an immune- mediated disorder and may be tumor-associated or idiopathic. OMS is one of a few steroid responsive disorders of childhood. KCTD7 mutations have been found in a patient with an atypical clinical presentation characterized by non-epileptic myoclonus and ataxia commencing in early infancy, abnormal opsoclonus-like eye movements, improvement of clinical symptoms under steroid treatment, and subsequent development of generalized epilepsy (PubMed:22638565). {ECO:0000269PubMed:22638565}.
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 4 experimentally validated interaction(s) in this database.
Experimentally validated
Total 4 [view]
Protein-Protein 3 [view]
Protein-DNA 0
Protein-RNA 0
DNA-DNA 1 [view]
RNA-RNA 0
DNA-RNA 0
Gene Ontology

Molecular Function
Accession GO Term
GO:0005515 protein binding
Biological Process
GO:0008219 cell death
GO:0051260 protein homooligomerization
Cellular Component
GO:0005829 cytosol
GO:0005886 plasma membrane
Protein Structure and Domains
PDB ID
InterPro IPR000210 BTB/POZ-like
IPR003131 Potassium channel tetramerisation-type BTB domain
IPR011333 BTB/POZ fold
PFAM PF02214
PRINTS
PIRSF
SMART SM00225
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt Q96MP8
PhosphoSite PhosphoSite-Q96MP8
TrEMBL
UniProt Splice Variant
Entrez Gene 154881
UniGene Hs.627532
RefSeq NP_001161433
HUGO HGNC:21957
OMIM 611725
CCDS CCDS55117
HPRD 13770
IMGT
EMBL AK056631 BC042482 CH236961 CH471140
GenPept AAH42482 BAB71236 EAL23735 EAX07919